# Enhanced Quitline Intervention in Smoking Cessation for Patients With Non-Metastatic Lung Cancer

> **NCT01457469** · PHASE1 · COMPLETED · sponsor: **Wake Forest University Health Sciences** · enrollment: 6 (actual)

## Conditions studied

- Limited Stage Small Cell Lung Cancer
- Recurrent Small Cell Lung Cancer
- Stage IA Non-small Cell Lung Cancer
- Stage IB Non-small Cell Lung Cancer
- Stage IIA Non-small Cell Lung Cancer
- Stage IIB Non-small Cell Lung Cancer
- Stage IIIA Non-small Cell Lung Cancer
- Stage IIIB Non-small Cell Lung Cancer
- Tobacco Use Disorder

## Interventions

- **OTHER:** questionnaire administration
- **PROCEDURE:** quality-of-life assessment
- **OTHER:** counseling intervention
- **OTHER:** internet-based intervention
- **BEHAVIORAL:** telephone-based intervention
- **OTHER:** educational intervention
- **DRUG:** nicotine replacement therapy
- **OTHER:** educational intervention

## Key facts

- **NCT ID:** NCT01457469
- **Lead sponsor:** Wake Forest University Health Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01
- **Primary completion:** 2012-01
- **Final completion:** 2012-05
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2018-08-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01457469

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01457469, "Enhanced Quitline Intervention in Smoking Cessation for Patients With Non-Metastatic Lung Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01457469. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*